| Evidence for an alternative glycolytic pathway in rapidly proliferating cells MG Vander Heiden, JW Locasale, KD Swanson, H Sharfi, GJ Heffron, ... Science 329 (5998), 1492-1499, 2010 | 747 | 2010 |
| Germline gain-of-function mutations in SOS1 cause Noonan syndrome AE Roberts, T Araki, KD Swanson, KT Montgomery, TA Schiripo, VA Joshi, ... Nature genetics 39 (1), 70-74, 2007 | 701 | 2007 |
| PTPN11 (Shp2) mutations in LEOPARD syndrome have dominant negative, not activating, effects MI Kontaridis, KD Swanson, FS David, D Barford, BG Neel Journal of Biological Chemistry 281 (10), 6785-6792, 2006 | 386 | 2006 |
| Tumor treating fields perturb the localization of septins and cause aberrant mitotic exit N Gera, A Yang, TS Holtzman, SX Lee, ET Wong, KD Swanson PloS one 10 (5), e0125269, 2015 | 228 | 2015 |
| AR and ER interaction with a p21-activated kinase (PAK6) SR Lee, SM Ramos, A Ko, D Masiello, KD Swanson, ML Lu, SP Balk Molecular endocrinology 16 (1), 85-99, 2002 | 193 | 2002 |
| Dexamethasone exerts profound immunologic interference on treatment efficacy for recurrent glioblastoma ET Wong, E Lok, S Gautam, KD Swanson British journal of cancer 113 (2), 232-241, 2015 | 168 | 2015 |
| The melanoma-associated transmembrane glycoprotein Gpnmb controls trafficking of cellular debris for degradation and is essential for tissue repair B Li, AP Castano, TE Hudson, BT Nowlin, SL Lin, JV Bonventre, ... The FASEB Journal 24 (12), 4767, 2010 | 164 | 2010 |
| Cabozantinib eradicates advanced murine prostate cancer by activating antitumor innate immunity A Patnaik, KD Swanson, E Csizmadia, A Solanki, N Landon-Brace, ... Cancer Discovery 7 (7), 750-765, 2017 | 140 | 2017 |
| Phenformin inhibits myeloid-derived suppressor cells and enhances the anti-tumor activity of PD-1 blockade in melanoma SH Kim, M Li, S Trousil, Y Zhang, MP di Magliano, KD Swanson, B Zheng Journal of Investigative Dermatology 137 (8), 1740-1748, 2017 | 138 | 2017 |
| Phosphatase-dependent and-independent functions of Shp2 in neural crest cells underlie LEOPARD syndrome pathogenesis RA Stewart, T Sanda, HR Widlund, S Zhu, KD Swanson, AD Hurley, ... Developmental cell 18 (5), 750-762, 2010 | 127 | 2010 |
| SHPS-1 is a scaffold for assembling distinct adhesion-regulated multi-protein complexes in macrophages JF Timms, KD Swanson, A Marie-Cardine, M Raab, CE Rudd, B Schraven, ... Current Biology 9 (16), 927-930, 1999 | 127 | 1999 |
| Metabolomics of human cerebrospinal fluid identifies signatures of malignant glioma JW Locasale, T Melman, S Song, X Yang, KD Swanson, LC Cantley, ... Molecular & Cellular Proteomics 11 (6), 2012 | 114 | 2012 |
| An overview of alternating electric fields therapy (NovoTTF Therapy) for the treatment of malignant glioma KD Swanson, E Lok, ET Wong Current neurology and neuroscience reports 16, 1-10, 2016 | 96 | 2016 |
| Regulation of in vitro and in vivo immune functions by the cytosolic adaptor protein SKAP-HOM M Togni, KD Swanson, S Reimann, S Kliche, AC Pearce, L Simeoni, ... Molecular and cellular biology, 2005 | 94 | 2005 |
| ATP-stimulated activation of the mitogen-activated protein kinases through ionotrophic P2X2 purinoreceptors in PC12 cells: difference in purinoreceptor sensitivity in two PC12 … KD Swanson, C Reigh, GE Landreth Journal of Biological Chemistry 273 (32), 19965-19971, 1998 | 91 | 1998 |
| Myeloid-derived itaconate suppresses cytotoxic CD8+ T cells and promotes tumour growth H Zhao, D Teng, L Yang, X Xu, J Chen, T Jiang, AY Feng, Y Zhang, ... Nature metabolism 4 (12), 1660-1673, 2022 | 90 | 2022 |
| Androgen receptor enhances p27 degradation in prostate cancer cells through rapid and selective TORC2 activation Z Fang, T Zhang, N Dizeyi, S Chen, H Wang, KD Swanson, C Cai, ... Journal of Biological Chemistry 287 (3), 2090-2098, 2012 | 85 | 2012 |
| SOS1 mutations are rare in human malignancies: Implications for Noonan syndrome patients KD Swanson, JM Winter, M Reis, M Bentires‐Alj, H Greulich, R Grewal, ... Genes, Chromosomes and Cancer 47 (3), 253-259, 2008 | 82 | 2008 |
| Heme-derived metabolic signals dictate immune responses G Canesin, SM Hejazi, KD Swanson, B Wegiel Frontiers in immunology 11, 66, 2020 | 74 | 2020 |
| Response assessment of NovoTTF‐100A versus best physician's choice chemotherapy in recurrent glioblastoma ET Wong, E Lok, KD Swanson, S Gautam, HH Engelhard, F Lieberman, ... Cancer medicine 3 (3), 592-602, 2014 | 67 | 2014 |
